Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Rothera Mark
Relationship:   President and CEO, Dir...
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   232,348    

Indirect Shares

  19,216      
Direct Value   $1,392,328    

Indirect Value

  $374,723      
Total Shares   251,564      
Total Value   $1,767,050      


Aegerion Pharmaceuticals, Inc.
 $0 PTC Therapeutics, Inc.
 $1,371,828 Orchard Therapeutics Plc
 $0 Viracta Therapeutics Ord Shs
 $20,500 Aegerion Pharmaceuticals, Inc.
 $0 PTC Therapeutics, Inc.
 $1,371,828 Orchard Therapeutics Plc
 $0 Viracta Therapeutics Ord Shs
 $20,500
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   0.0   
     Percentage Gain/Loss :
   -41.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aegerion Pharmaceuticals, Inc. AEGR Officer 2012-04-30 4,813 0    Premium*  
            PTC Therapeutics, Inc. PTCT Chief Commercial Officer 2017-05-24 33,739 2017-05-24 9,216    Premium*  
            Orchard Therapeutics Plc ORTX Officer, Director 2020-01-01 93,796 2020-01-01 10,000    Premium*  
            Viracta Therapeutics Ord Shs VIRX President and CEO, Dir... 2023-12-01 100,000 2023-11-30 0    Premium*  
* Premium Members only  

Records found :    42         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AEGR Aegerion Pharmaceuticals,... Global PresidentOfficer   •       –      –    2012-04-30 3 IO $0.00 $0 D/D 0 4,813 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2013-06-25 4 B $15.00 $375,000 D/D 25,000 25,000 2.74 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2014-09-15 4 AS $35.72 $289,910 D/D (8,000) 17,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2014-09-24 4 OE $10.85 $9,765 D/D 900 17,900 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2014-09-24 4 AS $42.88 $125,234 D/D (2,900) 15,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2014-09-25 4 AS $44.15 $448,225 D/D (10,100) 12,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2014-09-25 4 OE $10.85 $77,035 D/D 7,100 22,100 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2014-09-26 4 AS $46.90 $140,700 D/D (3,000) 9,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-01-13 4 OE $10.85 $59,675 D/D 5,500 11,500 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-01-13 4 AS $56.51 $492,655 D/D (8,500) 6,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-01-14 4 AS $58.62 $70,344 D/D (1,200) 6,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-01-14 4 OE $10.85 $13,020 D/D 1,200 7,200 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-01-16 4 OE $10.85 $24,955 D/D 2,300 8,300 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-01-16 4 AS $58.67 $134,941 D/D (2,300) 6,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-01-20 4 AS $60.02 $180,060 D/D (3,000) 3,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-02-23 4 AS $62.69 $1,504,310 D/D (23,000) 0 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-02-23 4 OE $10.85 $217,000 D/D 20,000 20,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-02-24 4 OE $10.85 $10,850 D/D 1,000 1,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-02-24 4 AS $67.70 $67,700 D/D (1,000) 0 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-02-25 4 OE $10.85 $119,350 D/D 11,000 11,000 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-02-25 4 AS $73.49 $808,390 D/D (11,000) 0 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-03-13 4 AS $76.36 $22,908 D/D (300) 0 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-03-13 4 OE $10.85 $3,255 D/D 300 300 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-03-17 4 OE $10.85 $116,095 D/D 10,700 10,700 0 -
PTCT PTC Therapeutics, Inc. Chief Commercial Officer   •       –      –    2015-03-17 4 AS $76.64 $820,048 D/D (10,700) 0 0 -

  42  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed